Facial recognition company Rank One Computing (ROC.US) plans to raise $23 million in an IPO. Its main customer is the US government.
Facial recognition software provider Rank One Computing has filed a $23 million IPO application.
Rank One Computing (ROC.US), which provides AI-based facial recognition and biometric verification software, submitted a listing application to the U.S. Securities and Exchange Commission on Wednesday, planning to raise up to $23 million through an initial public offering, with pricing terms yet to be disclosed.
ROC has developed proprietary AI software for biometric recognition, video analysis, and digital evidence analysis. Its products include the real-time video analysis platform ROC Watch, the ROC SDK for multimodal algorithms, the ROC ABIS for enterprise identity management, and the ROC Enroll for remote identity verification. ROC also generates revenue from research and development contracts, supporting workloads such as large-scale biometric matching, forensic categorization, access control, threat detection, and investigative analysis. The company serves U.S. federal agencies, defense and national security organizations, state and local law enforcement agencies, and regulated commercial sectors such as fintech, telecom, and critical infrastructure.
Based in Denver, Colorado, the company was founded in 2015 and generated revenue of $16 million for the 12-month period ending September 30, 2025. The company plans to list on the Nasdaq under the stock symbol ROC. Rank One Computing secretly submitted its listing application on August 13, 2025. Benchmark is the sole underwriter for this transaction.
Related Articles

Smart flying golden Thai(688443.SH): Celltrion's monoclonal antibody injection included in the 2025 National Medical Insurance Catalog.

HaiChuang Pharmaceuticals (688302.SH)Daon Zalu Amin soft capsules have been included in the 2025 National Medical Insurance Drug List.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)Innovative drugs Avimeplanib and Golirelin included in the new version of the national medical insurance directory.
Smart flying golden Thai(688443.SH): Celltrion's monoclonal antibody injection included in the 2025 National Medical Insurance Catalog.

HaiChuang Pharmaceuticals (688302.SH)Daon Zalu Amin soft capsules have been included in the 2025 National Medical Insurance Drug List.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)Innovative drugs Avimeplanib and Golirelin included in the new version of the national medical insurance directory.






